494 related articles for article (PubMed ID: 33982329)
1. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
Zhao JA; Nie W; Dong L; Liu W; Wei W
J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
[TBL] [Abstract][Full Text] [Related]
2. circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.
Liu Q; Wang C; Jiang Z; Li S; Li F; Tan HB; Yue SY
J Cell Mol Med; 2020 Dec; 24(24):14306-14315. PubMed ID: 33135290
[TBL] [Abstract][Full Text] [Related]
3. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
4. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
Li L; Xiao C; He K; Xiang G
IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
[TBL] [Abstract][Full Text] [Related]
5. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
[TBL] [Abstract][Full Text] [Related]
6. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
7. CircSOD2 Contributes to Tumor Progression, Immune Evasion and Anti-PD-1 Resistance in Hepatocellular Carcinoma by Targeting miR-497-5p/ANXA11 Axis.
Ye R; Lu X; Liu J; Duan Q; Xiao J; Duan X; Yue Z; Liu F
Biochem Genet; 2023 Apr; 61(2):597-614. PubMed ID: 36008700
[TBL] [Abstract][Full Text] [Related]
8. Curcumin restrains hepatocellular carcinoma progression depending on the regulation of the circ_0078710/miR-378b/PRIM2 axis.
Chen Q; Guo H; Zong Y; Zhao X
J Recept Signal Transduct Res; 2022 Jun; 42(3):313-324. PubMed ID: 34139933
[TBL] [Abstract][Full Text] [Related]
9. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
10. Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate
Wu M; Sun T; Xing L
Cancer Biother Radiopharm; 2023 Dec; 38(10):708-719. PubMed ID: 33021399
[No Abstract] [Full Text] [Related]
11. Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
Liu J; He X; Zou Y; Wang K
Dig Dis Sci; 2022 Jun; 67(6):2269-2282. PubMed ID: 34231101
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
13. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
Fu D; Ji Q; Wang C; Yu L; Yu R
Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
Liu C; Ren C; Guo L; Yang C; Yu Q
Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
[TBL] [Abstract][Full Text] [Related]
15. A novel curcumin analogue is a potent chemotherapy candidate for human hepatocellular carcinoma.
Zhao JA; Sang MX; Geng CZ; Wang SJ; Shan BE
Oncol Lett; 2016 Nov; 12(5):4252-4262. PubMed ID: 27895800
[TBL] [Abstract][Full Text] [Related]
16. Matrine inhibits hepatocellular carcinoma cell malignancy through the circ_0013290/miR-139-5p/MMP16 pathway.
Chang X; Huang Z; Zhang Z; Pan W; Song C
Histol Histopathol; 2023 Oct; 38(10):1179-1192. PubMed ID: 36594718
[TBL] [Abstract][Full Text] [Related]
17. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
Chen W; Li Y; Zhong J; Wen G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
[TBL] [Abstract][Full Text] [Related]
18. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
19. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.
Zhu H; Zhang H; Pei Y; Liao Z; Liu F; Su C; Liu Y; Dong R; Song J; Zhang X; Fan Y; Liang H; Zhang B; Chen X
J Exp Clin Cancer Res; 2021 Feb; 40(1):57. PubMed ID: 33541391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
